The synthesis and evaluation of novel bis-triazole derivatives, designed to evaluate their antimicrobial activity against clinically relevant pathogens and to establish structure-activity relationships for future optimization, provide a basis for further optimization of triazole-based antimicrobial agents.
Abstract
Abstract The 1,2,4-triazole nucleus is a privileged scaffold in medicinal chemistry, as it is present in many clinically approved antifungal, anticancer and antiviral agents. However, the development of new triazole-based derivatives with better potency and safety profiles is demanded due to the emergence of antimicrobial resistance. The present study was designed to synthesize novel bis-triazole derivatives, to evaluate their antimicrobial activity against clinically relevant pathogens and to establish structure-activity relationships for future optimization. A new series of bis-triazole derivatives (2–14) was synthesized starting from isophthalic acid as the key intermediate 1. All compounds were characterized by FT-IR, NMR, mass spectrometry and analysis. The antimicrobial activity was determined by disk diffusion, MIC, MBC and MTT cytotoxicity assays. Molecular docking was done using redocking validation (RMSD = 0.92 Å) against DNA gyrase B (PDB: 1KZN). Compound 13 showed the best antibacterial activity (MIC = 12.5 µg/mL for K. pneumoniae; inhibition zone: 23 mm for E. coli). Compound 9 showed potent antifungal activity (19 mm vs C. albicans; MIC = 12.5 µg/mL vs MRSA). Selectivity indices ranged between 5 and 40 indicating good safety profiles. Docking showed that compound 13 had a binding energy of −8.8 kcal/mol with important interactions with ASP73, ARG136 and CYS393. First report of quantitative MIC, MBC and cytotoxicity data for this class of bis-triazole derivatives with evaluation against MDR clinical isolates (MRSA and K. pneumoniae). The validated docking model (RMSD = 0.92 Å) provides a reliable tool for future structure-based design. Compound 9 was found to be a promising oral antifungal lead (SI = 20) and compound 13 a candidate for topical antibacterial applications (SI = 10). These findings provide a basis for further optimization of triazole-based antimicrobial agents. GRAPHICAL ABSTRACTFlowchart illustrating the synthesis, profiling, docking, and toxicity evaluation of Bis-1,2,4-Triazole Diformimidate derivatives.The diagram presents a circular flowchart centered on "Bis-1,2,4-Triazole Diformimidate Derivatives," labeled '9'. Surrounding this structure are four main sections: "Synthesis & Characterization" with lab equipment and techniques (FT-IR, NMR, MS), "Molecular Docking" showing binding to the 1KZN protein, "Antimicrobial Activity" with illustrations of bacteria and fungi highlighting effectiveness, and "Toxicity Evaluation" featuring a spider web plot indicating low predicted toxicity for several categories. "ADME Profiling" indicates drug-likeness and bioavailability. Arrows represent the processes' interconnected workflow.
A series of peptide–heterocycle conjugates was systematically designed and synthesized using solid‐phase peptide synthesis (SPPS), featuring octapeptide‐triazole conjugates modified with a triazole‐based moiety to create innovative antimicrobial agents characterized by enhanced stability and efficacy.
Jigar Bhavsar, S. Tivari, S. S. Pati et al.· Journal of Peptide Science· 0 citations
Overall, these findings identify benzo[h]quinoline-based candidates, particularly compound 10, as promising scaffolds for further antimicrobial drug development.
E. El-Helw, Abeer M. El-Naggar, Mahmoud Kamal et al.· RSC Advances· 0 citations
The data suggest para-methoxy substitution improves antibacterial activity, meriting further studies on solubility enhancement, metabolic stability and in vivo validation.
Ankit Goel, K. Yadav, Tanya Jain et al.· Oriental Journal of Chemistr...· 0 citations
INTRODUCTION
The 1,2,3-triazole scaffold is a privileged heterocyclic motif in medicinal chemistry owing to its chemical stability, click-chemistry accessibility, and broad biological activity. This review examines advances in 1,2,3-triazole-based hybrids, emphasizing antitubercular activity against drug-sensitive and...
Mausin Khan, M. Ajmal, N. Shanthi et al.· Mini-Reviews in Medical Chem...· 0 citations
These triazine-based bis-sulfonamide derivatives represent a promising therapeutic scaffold for the development of next-generation bacterial DNA topoisomerase inhibitors and are evaluated for their in vitro antibacterial efficacy and non-cytotoxic profiles.
Tuhfa, M. Arshad, Mehnaj et al.· Russian journal of bioorgani...· 0 citations
Antimicrobial resistance (AMR) and cancer are among the most extensively studied areas that still require further improvement. In the present study, four new compounds were synthesized via Claisen-Schmidt condensation reaction followed by ring closure, yielding pyrazoline heterocyclic derivatives bearing a thiophene mo...
I. S. Mahdi, Ghosoun Laftaa Mohsen, A. Abdula et al.· Journal of Genetic Engineeri...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.